Ikarian Capital’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.22M Sell
262,740
-60,000
-19% -$736K 0.62% 29
2025
Q1
$3.55M Buy
+322,740
New +$3.55M 0.44% 30